Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
Morrissey
P E
PE
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8062.
Lorber
K M
KM
Marcarelli
M
M
Bia
M J
MJ
Kliger
A S
AS
Lorber
M I
MI
D015703:Antigens, CD / Q000096:biosynthesis*; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000096:biosynthesis*; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000209:etiology / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008232:Lymphoproliferative Disorders / Q000139:chemically induced; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology / Q000276:immunology; D016377:Organ Transplantation; D014412:Tumor Virus Infections / Q000209:etiology / Q000276:immunology*
D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D007166:Immunosuppressive Agents